The primary objective of this study is to demonstrate that ultra-hypofractionation of
prostate cancer does not increase urinary toxicity as defined by the EPIC-26 GU domain
patient reported outcome.

The purpose of this study is to learn if lifestyle changes and counseling along with standard
medical care, compared to standard medical care alone, can prevent heart problems and
diabetes in men who are receiving ADT for prostate cancer treatment.